Jonathan C. Javitt's Insider Trades & SAST Disclosures
Jonathan C. Javitt's most recent trade in NRX Pharmaceuticals Inc was a trade of 40,000 Common Stock done at an average price of $1.2 . Disclosure was reported to the exchange on Dec. 17, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Jonathan C. Javitt.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| NRX Pharmaceuticals Inc | Jonathan C. Javitt | Director, Chairman and Chief Scientist, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 1.17 per share. | 17 Dec 2024 | 40,000 | 84,634 | - | 1.2 | 46,800 | Common Stock |
| NRX Pharmaceuticals Inc | Jonathan C. Javitt | Director, Chief Scientist, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.33 per share. | 23 Aug 2023 | 100,000 | 446,332 | - | 0.3 | 33,000 | Common Stock |
| NRX Pharmaceuticals Inc | Jonathan C. Javitt | Director, Chief Scientist, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.32 per share. | 22 Aug 2023 | 200,000 | 346,332 | - | 0.3 | 64,400 | Common Stock |
| NRX Pharmaceuticals Inc | Jonathan C. Javitt | Director, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 31 Dec 2022 | 300,000 | 14,468,329 | - | 0 | Common Stock, par value $0.001 per share | |
| NRX Pharmaceuticals Inc | Jonathan C. Javitt | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 1.00 per share. | 07 Dec 2022 | 400,000 | 12,899,997 | - | 1 | 400,000 | Common Stock, par value $0.001 per share |
| NRX Pharmaceuticals Inc | Jonathan C. Javitt | Director, Chief Scientist, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.58 per share. | 01 Jun 2022 | 100,000 | 146,332 | - | 0.6 | 58,000 | Common Stock |
| NRX Pharmaceuticals Inc | Jonathan C. Javitt | Director, Chief Executive Officer, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 May 2021 | 13,348,997 | 13,348,997 | - | - | Common Stock | |
| NRX Pharmaceuticals Inc | Jonathan C. Javitt | Director, Chief Executive Officer, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 May 2021 | 1,422,000 | 1,422,000 | - | - | Common Stock | |
| NRX Pharmaceuticals Inc | Jonathan C. Javitt | Director, Chief Executive Officer, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 May 2021 | 46,332 | 46,332 | - | - | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges